Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Nov 30, 2023
Open Peer Review Period: Nov 30, 2023 - Jan 25, 2024
Date Accepted: Oct 30, 2024
(closed for review but you can still tweet)
A supervised explainable machine learning model for perioperative neurocognitive disorder in liver-transplantation patients: A retrospective study with external validation on the Medical Information Mart for Intensive Care Ⅳ database
ABSTRACT
Background:
Patients undergoing liver transplantation (LT) are at risk of perioperative neurocognitive dysfunction (PND), which significantly affects the patients’ prognosis.
Objective:
This study used machine learning (ML) algorithms to extract critical predictors and develop an ML model to predict PND among LT recipients.
Methods:
In this retrospective study, data from 958 patients who underwent LT between January 2015 and January 2020 were extracted from the Third Affiliated Hospital of Sun Yat-sen University. Six ML algorithms were used to predict post-LT PND, and model performance was evaluated using area under the receiver operating curve (AUC), accuracy, sensitivity, specificity, and F1 scores. The best-performing model was additionally validated using a temporal external dataset including 309 LT cases from February 2020 to August 2022, and an independent external dataset extracted from the Medical Information Mart for Intensive Care Ⅳ (MIMIC-Ⅳ) database including 325 patients.
Results:
In the development cohort, 201 out of 751 patients (33.5%) were diagnosed with PND. The logistic regression (LR) model achieved the highest AUC (0.799) in the internal validation set, with comparable AUC in the temporal external (0.826) and MIMIC-Ⅳ validation sets (0.72). The top three features contributing to post-LT PND diagnosis were the preoperative overt hepatic encephalopathy, platelet level, and postoperative SOFA score, as revealed by the Shapley additive explanations method.
Conclusions:
A real-time LR model-based online predictor of post-LT PND was developed, providing a highly interoperable tool for use across medical institutions to support early risk stratification and decision-making for the LT recipients. Clinical Trial: Not applicable.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.